Home
About
Overview
Sharing Data
ORCID
Help
History (52)
A contextual fear conditioning paradigm in head-fixed mice exploring virtual reality.
Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites.
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors.
Emerging biomarkers and molecular targets for precision medicine in cervical cancer.
Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.
See All 52 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.
Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders. Cancer Treat Rev. 2014 Feb; 40(1):197-203.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Eye
Eye Diseases
Humans
Lung Neoplasms
Molecular Targeted Therapy
Protein Kinase Inhibitors
authors with profiles
Marina Chiara Garassino